Brief: Okyo Pharma Ltd Announces Pricing Of $20 Million Public Offering Of Ordinary Shares
13/02/2026 03:23
Feb 13 (Reuters) - OKYO Pharma Ltd OK11.MU: OKYO PHARMA LTD: ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING OF ORDINARY SHARES OKYO PHARMA LTD: UNDERWRITTEN PUBLIC OFFERING OF 10,815,000 ORDINARY SHARES AT AN OFFERING PRICE OF $1.85 PER ORDINARY SHARE Source text: ID:nGNX81hXRn Further company coverage: OK11.MU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on OKYO Pharma
See all newsBrief: Okyo Pharma's Chairman Gabriele Cerrone Now Holds 20.55% Of Co's Issued Share Capital
Brief: Okyo Pharma Announces Scientific Advisory Board Meeting And Urcosimod Data Presentation During Ascrs Annual Meeting
Brief: Okyo Pharma Ltd Announces Pricing Of $20 Million Public Offering Of Ordinary Shares
Brief: OKYO Pharma To Offer Up To $200 Million In Securities
Brief: FDA Approves Compassionate Use Of Urcosimod (0.05%) For The Treatment Of Neuropathic Corneal Pain